Uncategorized

Here are the top 25 cancer stories Becker's reported on in 2023:

Welireg (belzutifan), a Merck drug co-developed by researchers at Dallas-based UT Southwestern Medical Center, gained a new approval Dec. 14.

Syracuse, N.Y.-based St. Joseph's Health is partnering with Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., to bring more oncology services to local residents.

Experts have long known that where a patient lives can have an effect on health outcomes, but a new study from NYU Langone finds that it can also affect how likely a patient is to fill their prescription for heart…

NYU Langone Health in New York City has appointed Michelle Bloom, MD, as system director of its cardio-oncology program, effective Dec. 1.

Indianapolis-based Community Health Network is adding two cancer treatments to its cancer center thanks to a partnership with Houston-based MD Anderson Cancer Center, Inside Indiana Business reported Dec. 14.

Researchers at Albuquerque-based University of New Mexico School of Medicine have created a new LDL cholesterol vaccine.

UChicago Medicine has received a $20 million gift to support the development of a cancer care and research facility that's slated to open in 2027. 

A new year means new goals and strategies for cancer centers across the nation.

Kennewick, Wash.-based Trios Health will temporarily end its medical oncology services Dec. 13 due to staff shortages, the Tri-City Herald reported.